Lawsuit Targeting Corcept’s Cushing’s Disease Drug Proceeds in Mass. Federal Court



DOCUMENTS
  • Order


BOSTON — A Massachusetts federal judge has dismissed as preempted product labeling failure-to-warn claims in an action involving reproductive injuries allegedly caused by the Cushing’s disease drug, Korlym, because they seek to challenge warnings approved by the Food and Drug Administration.

However, in a Nov. 10 order, Judge William G. Young of the U.S. District Court for the District of Massachusetts allowed the warning claims based upon reports defendants Corcept Therapeutics Inc. and Optime Care Inc., made to the FDA, ruling that dismissal would be premature given the unsettled state of Massachusetts law.

In addition, Judge Young allowed failure-to-monitor …

FIRM NAMES
  • Bennerotte & Associates
  • Freeman Mathis & Gary LLP
  • Gilbert Alden Barbosa PLLC
  • Manning Gross Massenburg
  • Zisson & Jacobs





UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Hair Straightener & Social Media Litigation

January 25, 2023 - Miami Beach, FL
Fontainebleau Miami Beach

MORE DETAILS



HarrisMartin's Camp Lejeune Litigation Conference: Navigating the Complexities - Where Do We Go From Here?

December 08, 2022 - New York, NY
InterContinental® New York Times Square

MORE DETAILS